Tixagevimab Active Not Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

Back to Tixagevimab
IndicationsStatusPurposePhase
Active Not RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04625972Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults
NCT04625725Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.